Includes all AIM, ASX, CBOE, CSE, LSE, TSX and TSXV companies with US symbols
Loading...
Get Featured
Pink

AXIMAxim Biotechnologies, Inc.

Loading price...
Loading price changes...
Loading market cap...

Price Chart

Loading chart...

About Axim Biotechnologies, Inc. (AXIM)

Axim Biotechnologies, Inc. (AXIM) is a Biotechnology company headquartered in San Diego, CA, United States whose shares trade over-the-counter on the Pink tier.

Axim Biotechnologies, Inc. is a leading developer of diagnostic healthcare solutions serving to enhance the health of people. Through the development of diagnostic solutions that quickly and accurately diagnose various diseases, our products allow healthcare workers to quickly test and treat at the point-of-care, which leads to improved patient outcomes and provides numerous economic benefits to the healthcare system. Axim's core competencies include development of rapid lateral flow immunoassays, reagents and monoclonal antibody development for such assays.

Products and services

Axim Biotechnologies, Inc. is a leading developer of diagnostic healthcare solutions serving to enhance the health of people. Through the development of diagnostic solutions that quickly and accurately diagnose various diseases, our products allow healthcare workers to quickly test and treat at the point-of-care, which leads to improved patient outcomes and provides numerous economic benefits to the healthcare system. Axim’s core competencies include development of rapid lateral flow immunoassays, reagents and monoclonal antibody development for such assays. Our current products fall into these categories: (1) Eye Health, wherein we acquired two FDA cleared 510(k) tests for dye eye disease and have internally developed a third assay; and (2) SARS-CoV-2 neutralizing antibody tests.

AXIM key facts

Ticker symbol
AXIM
Market tier
Pink
Headquarters
San Diego, CA, United States
Country of incorporation
US
Year of incorporation
2010
Employees
8
Estimated market cap
$1.46M (as of Apr 10, 2025)
Shares outstanding
332,761,010
Reporting standard
Alternative Reporting Standard
Audit status
Audited
Fiscal year end
12/31

Axim Biotechnologies, Inc. leadership

  • Catalina Valencia — President
  • Robert T. Malasek — CFO
  • Phillip E Koehnke APC — Corporate Counsel

Explore more: Biotechnology stocks · Healthcare sector · Pink stocks · OTC stocks starting with A

Press Releases

Loading press releases...

Latest News

Loading news...

SPONSORED
Loading ads...
SPONSORED
Loading ads...

Key Statistics

Major Holders

Loading...

Loading modules...

AI-Powered Stock Analysis

Get a concise 600-word investment analysis for Axim Biotechnologies, Inc. (AXIM) prioritizing the most recent news and developments. Our AI focuses on today's breaking news first, then recent company developments, business updates, strategic initiatives, and current market positioning. Get the most relevant and current analysis available.

Still in beta - Please send feedback after generating your analysis to help us improve!

Smart investment analysis prioritizing breaking news, then recent company developments and strategic insights - completely free!

By submitting, you agree to our Privacy Policy and Terms of Service. We'll add you to our newsletter but you can unsubscribe at any time.

Investor Reviews

Investor Reviews (0)

Loading reviews...

Get Verified

Is this your company?

Get verified and take control of your company page. Add your verified badge, edit information, and showcase your business to investors.

Low Cost
Quick Setup
SPONSORED
Loading ads...
SPONSORED
Loading ads...
SPONSORED
Loading ads...
SPONSORED
Loading ads...

Company Profile

Loading company profile data...

Contact Information

Fax
Not provided
Investor Relations Email
Not provided
Headquarters Address
6048 Cornerstone Ct W
San Diego, CA, 92121
United States

Company Leadership

Company Officers

Catalina Valencia
President
Robert T. Malasek
CFO
Phillip E Koehnke APC
Corporate Counsel

Social Media

Business Details

Stock Details

Loading modules...